Trials / Completed
CompletedNCT02774161
B-mode Ultrasound Imaging in Detecting Early Liver Cancer
Quantitative Ultrasound Spectroscopy to Early HCC
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This pilot trial studies how well B-mode ultrasound imaging works in detecting liver cancer that is early in its growth and may not have spread to other parts of the body. Diagnostic procedures, such as B-mode ultrasound imaging, may help find and diagnose liver cancer and find out how far the disease has spread.
Detailed description
PRIMARY OBJECTIVES: I. To investigate the use of quantitative ultrasound spectroscopy to detect early hepatocellular carcinoma (HCC) as an inexpensive and widely available quantitative (i.e. robust) method to confirm disease in developing countries. OUTLINE: Patients undergo B-mode ultrasound imaging of the liver over 15 minutes.
Conditions
- Cirrhosis
- Early Hepatocellular Carcinoma
- Fibrosis
- Stage I Hepatocellular Carcinoma
- Stage II Hepatocellular Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ultrasound Tomography | Undergo B-mode ultrasound imaging |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-06-19
- Completion
- 2017-06-19
- First posted
- 2016-05-17
- Last updated
- 2021-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02774161. Inclusion in this directory is not an endorsement.